AGG Talks: Government Insight for Life Sciences Leaders | How Medicare Regulations Could Affect Access to Gender-Affirming Care: Implications for Life Sciences Companies
42 CFR Part 2 Final Rule: What’s Changing and What Do You Need to Know? – Diagnosing Health Care Video Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 257: Biogen’s $2B Investment in North Carolina’s RTP with Nicole Murphy
Hospice Insights Podcast - If Only I Knew… Avoiding the Most Common Mistakes with the 855
H-1B Enforcement Tightened, Fertility Benefits Expanded, Gender Identity Protection Setback - #WorkforceWednesday® - Employment Law This Week®
Workplace Mental Health: Strategies for Stress and Anxiety Relief
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 256: AI, Advocacy & Clinical Trials with Sophia McLeod of ACRO
Current Tailwinds in Women’s Health - What Do They Mean for Your Business? – Diagnosing Health Care Video Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 255: Private Equity Essentials for Life Sciences Organizations and Startups
The IP Future: Intellectual Property Challenges in AI Health Care Contracts – The Good Bot: Artificial Intelligence, Health Care, and the Law
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 254: Responsible AI in Healthcare with Dr. Justin Collier of Lenovo
What's New with the False Claims Act?
Hospice Insights Podcast - Making Palliative Care a Win-Win-Win: A Conversation with Dr. Bethany Snider, Chief Medical Officer, Hosparus Health
Exploring Long-Term Home Care Solutions with Albert Eshoo & Joyce Barocas
Employee Benefits and Executive Compensation Preparing for 2026 – Top Five Health and Welfare Updates — Troutman Pepper Podcast
AGG Talks: Government Insight for Life Sciences Leaders - Episode 2: DOJ’s Shifting Enforcement: CPB Disbanding, Counterfeit Drug Focus, and Gender-Affirming Care Investigations
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 253: The Rise of Ambulatory Surgery Centers with Mark Wainner of ASCA
FTC Backs Off Non-Compete Ban, Warns Health Care Employers - #WorkforceWednesday® - Employment Law This Week®
The Latest on Value Based Care
Navigating Women's Health with Rachel Welch
This joint webinar presented by Buchalter Law Firm and COPE Health Solutions will explore the rise in disputes between Accountable Care Organizations (ACOs) and enablement companies, examining common sources for these...more
At this time of year, healthcare providers may want to give gifts to patients, referring providers, or other sources of business. In doing so, providers should beware the risks that giving or receiving gifts pose under...more
After the longest shutdown in American history, both the House and Senate return this week with a heavy workload before funding for most government agencies expires on January 30. In addition to appropriations, Congress...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
Despite the rapid invention and widespread use of artificial intelligence (AI), the federal government is just beginning to shape the regulatory landscape. In the absence of comprehensive federal AI regulations, private...more
Drilling down to the factual narrative that you need to extract from medical records can feel like spinning straw into gold. These records are often full of patient information and clinical details. Vastly different reporting...more
As payer audits become more frequent and complex, laboratories and healthcare providers must be equipped to respond effectively. Labs are especially vulnerable due to high-cost services and billing complexity. Triggers...more
In the past decade, there has been a significant increase in the utilization of Applied Behavioral Analysis (ABA) therapy, in large part because of expanded coverage under all Medicaid programs since 2022. Both federal and...more
On July 2, 2025, the Department of Health and Human Services Office of Inspector General (OIG) published Advisory Opinion 25-07, which concluded that a pharmaceutical manufacturer’s proposed arrangement to sponsor a free,...more
On November 12, 2025, President Trump signed H.R. 5371 the “Continuing Appropriations, Agriculture, Legislative Branch, Military Construction, and Veterans Affairs and Extensions Act, 2026” (the Act). The Act ended the...more
As macro trends such as population growth, ageing demographics, and co-morbidities place increasing pressure on healthcare systems, investors are once again seeking out compelling opportunities in the healthcare services...more
Below is a tracker of healthcare-related executive orders (EOs) issued by the Trump administration, including overviews of each EO and the date each EO was signed. We will regularly update this tracker as additional EOs are...more
The Joint Commission (JC) is evolving its accreditation program and, among other programmatic changes, has announced two major initiatives effective January 1, 2026: the launch of its Accreditation 360 model, including an...more
It has been a busy year for European financing markets, with robust demand for refinancings driving volume. The fourth quarter of 2025 likely will see more transactions coming to market in preparation for an even livelier...more
The food supplement market in Germany is growing rapidly, fuelled by health trends, an ageing population, innovative online marketing and direct-to-consumer brands. This dynamic environment has also driven strong M&A...more
Here are curated AG and federal regulatory news stories highlighting key areas in which state and federal regulators’ decisions are having an impact across the US: •Needle Little Transparency: Alabama AG Targets...more
In a new draft guidance, issued on October 29, 2025, the FDA proposed major updates to simplify biosimilarity studies and potentially reduce clinical testing for therapeutic protein products. ...more
The Internal Revenue Service (IRS) announced the 2026 cost-of-living adjustments to the dollar limitations for qualified retirement plans and other benefits, and the Social Security Administration announced its own...more
For many years, patients who sustained a mild traumatic brain injury, often referred to simply as a concussion, were told that their symptoms should resolve within a few weeks or months. ...more
On November 6, 2025, Hikma announced the U.S. launch of Starjemza™ (ustekinumab-hmny), a biosimilar of Janssen / Johnson & Johnson’s Stelara® (ustekinumab). Starjemza™ is approved for all the reference product’s indications,...more
On Oct. 31, the Centers for Medicare & Medicaid Services (CMS) released the 2026 Medicare Physician Fee Schedule Final Rule, wherein it established the Ambulatory Specialty Model (ASM) – a mandatory alternative payment model...more
On November 6, 2025, the Centers for Medicare & Medicaid Services (CMS) announced a new drug payment model designed to make Most Favored Nation (MFN)-level prices available to state Medicaid programs via manufacturer rebates....more
In October, two medical transportation companies were charged with or indicted for fraud in New York. The owner of Pearl Transit Corp. (“Pearl”), Jael Watts, was accused of running a sham transportation service that...more
Insight, innovation, and practical strategy for professionals in the managed care space - Compliance professionals in managed care face an ever-changing landscape shaped by evolving regulations, emerging risks, and...more
The U.S. Food and Drug Administration (FDA) recently revised its final guidance, How to Prepare a Pre-Request for Designation (Pre-RFD). ...more
